LRAP vs Clavanin A
Head-to-head comparison of LRAP (Leucine-Rich Amelogenin Peptide (LRAP)) and Clavanin A (Clavanin A (tunicate-derived antimicrobial peptide)) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | LRAP | Clavanin A |
|---|---|---|
| Category | Dental & Oral | Marine-Derived |
| Full Name | Leucine-Rich Amelogenin Peptide (LRAP) | Clavanin A (tunicate-derived antimicrobial peptide) |
| Molecular Weight | approx. 6.6 kDa | ~2.6 kDa |
| Half-Life | unknown | NR |
| Amino Acids | 59 | 23 |
| Typical Dose | — | NR |
| Route | local biomaterial | in vitro|topical preclinical |
| Purity | ≥98% | ≥98% |
| Studies Count | 85 | 83 |
| Research Status | Pre-clinical | Pre-clinical |
LRAP Benefits
- ✓enamel/dentin regeneration
- ✓odontogenic signaling
- ✓mineralization support
Clavanin A Benefits
- ✓antibacterial
- ✓anti-inflammatory
- ✓wound-healing lead
LRAP Dosing
No dosing data available
Clavanin A Dosing
NR|NR
LRAP Side Effects
- ⚠experimental only
- ⚠unknown immunogenicity
- ⚠biomaterial-dependent effects
Clavanin A Side Effects
- ⚠hemolysis at high concentrations
- ⚠immunogenicity risk
- ⚠protease sensitivity
Research Overview
LRAP
LRAP is one of the better-known amelogenin-derived peptides in regenerative dentistry because it can influence mineralization-related cell behavior. It remains a research peptide, but it is highly relevant to enamel repair and tooth-tissue engineering.
Clavanin A
Preclinical work supports broad antibacterial activity and some host-modulating effects, especially in skin and wound models. Activity can be improved through sequence optimization and formulation strategies.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.